Sarepta Therapeutics, Inc.
DE ˙ DB ˙ US8036071004
13,84 € ↓ -0,08 (-0,57%)
2026-06-04
DEL PRIS
SecurityDE:AB3A / Sarepta Therapeutics, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,596,993 shares
Latest Disclosed Value $ 56,510,595
Morgan Stanley reports 35.78% increase in ownership of AB3A / Sarepta Therapeutics, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,596,993 shares of Sarepta Therapeutics, Inc. (DE:AB3A) valued at $46,680,949 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,912,635 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 35.78% during the quarter. The current value of the position is $35,942,383 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F SAREPTA THERAPEUTICS COM 803607100 2,596,993 684,358 35.78 56,511 37.30 0.0034
2026-05-27 2025-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,912,635 -35,724 -1.83 41,160 9.63 0.0025
2026-02-13 2025-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,912,635 -35,724 41,160 0.0025
2026-05-27 2025-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,948,359 461,433 31.03 37,545 47.66 0.0023
2025-11-14 2025-09-30 13F SAREPTA THERAPEUTICS COM 803607100 1,948,359 461,433 37,545 0.0023
2025-08-15 2025-06-30 13F SAREPTA THERAPEUTICS COM 803607100 1,486,926 -485,196 -24.60 25,426 -79.80 0.0017
2025-05-15 2025-03-31 13F SAREPTA THERAPEUTICS COM 803607100 1,972,122 980,467 98.87 125,861 4.38 0.0090
2025-05-15 2024-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 991,655 38,551 4.04 120,576 1.30 0.0084
2025-02-14 2024-12-31 13F SAREPTA THERAPEUTICS COM 803607100 991,655 38,551 120,576 0.0084
2025-05-14 2024-09-30 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 953,104 -1,670,257 -63.67 119,033 -71.28 0.0086
2025-02-14 2024-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 953,104 -1,670,257 119,033 0.0086
2024-11-14 2024-09-30 13F SAREPTA THERAPEUTICS COM 803607100 953,104 -1,670,257 119,033 0.0010
2025-05-14 2024-06-30 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 2,623,361 1,734,928 195.28 414,491 260.38 0.0321
2024-10-17 2024-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 2,623,361 1,734,928 414,491 0.0321
2024-08-14 2024-06-30 13F SAREPTA THERAPEUTICS COM 803607100 2,623,361 1,734,928 414,491 0.0321
2024-10-17 2024-03-31 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 888,433 -491,716 -35.63 115,017 -13.58 0.0092
2024-08-16 2024-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 888,433 -491,716 115,017 0.0011
2024-05-15 2024-03-31 13F SAREPTA THERAPEUTICS COM 803607100 888,433 -491,716 115,017 0.0092
2024-08-16 2023-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 1,380,149 524,705 61.34 133,088 28.34 0.0117
2024-02-13 2023-12-31 13F SAREPTA THERAPEUTICS COM 803607100 1,380,149 524,705 133,088 0.0117
2023-11-15 2023-09-30 13F SAREPTA THERAPEUTICS COM 803607100 855,444 -120,906 -12.38 103,697 -7.26 0.0105
2023-08-14 2023-06-30 13F SAREPTA THERAPEUTICS COM 803607100 976,350 86,844 9.76 111,812 -8.80 0.0110
2023-05-15 2023-03-31 13F SAREPTA THERAPEUTICS COM 803607100 889,506 432,453 94.62 122,601 107.01 0.0131
2023-02-14 2022-12-31 13F SAREPTA THERAPEUTICS COM 803607100 457,053 60,786 15.34 59,225 35.21 0.0067
2022-11-14 2022-09-30 13F SAREPTA THERAPEUTICS COM 803607100 396,267 -21,439 -5.13 43,803 39.90 0.0060
2022-10-27 2022-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 417,706 47,190 12.74 31,310 8.17 0.0041
2022-08-15 2022-06-30 13F SAREPTA THERAPEUTICS COM 803607100 417,706 47,190 31,310 0.0041
2022-10-27 2022-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 370,516 133,013 56.00 28,945 35.34 0.0039
2022-05-13 2022-03-31 13F SAREPTA THERAPEUTICS COM 803607100 370,516 133,013 28,945 0.0039
2022-02-14 2021-12-31 13F SAREPTA THERAPEUTICS COM 803607100 237,503 -101,766 -30.00 21,387 -31.83 0.0026
2021-11-15 2021-09-30 13F SAREPTA THERAPEUTICS COM 803607100 339,269 14,573 4.49 31,375 24.30 0.0042
2021-08-23 2021-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 324,696 132,095 68.58 25,242 75.85 0.0033
2021-08-16 2021-06-30 13F SAREPTA THERAPEUTICS COM 803607100 324,696 132,095 25,242 0.0007
2021-05-17 2021-03-31 13F SAREPTA THERAPEUTICS COM 803607100 192,601 -103,755 -35.01 14,354 -71.59 0.0021
2021-02-16 2020-12-31 13F SAREPTA THERAPEUTICS COM 803607100 296,356 92,845 45.62 50,525 76.79 0.0078
2020-11-13 2020-09-30 13F SAREPTA THERAPEUTICS COM 803607100 203,511 -8,169 -3.86 28,579 -15.80 0.0055
2020-08-14 2020-06-30 13F SAREPTA THERAPEUTICS COM 803607100 211,680 -128,831 -37.83 33,942 1.90 0.0075
2020-05-26 2020-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 340,511 51,082 17.65 33,309 -10.82 0.0091
2020-05-15 2020-03-31 13F SAREPTA THERAPEUTICS COM 803607100 340,511 51,082 33,309 2,558.8256
2020-02-14 2019-12-31 13F SAREPTA THERAPEUTICS COM 803607100 289,429 80,818 38.74 37,349 137.69 0.0087
2019-11-14 2019-09-30 13F SAREPTA THERAPEUTICS COM 803607100 208,611 -65,789 -23.98 15,713 -62.31 0.0042
2019-08-14 2019-06-30 13F SAREPTA THERAPEUTICS COM 803607100 274,400 110,095 67.01 41,695 112.91 0.0111
2019-05-15 2019-03-31 13F SAREPTA THERAPEUTICS COM 803607100 164,305 -2,877 -1.72 19,583 7.34 0.0055
2019-02-14 2018-12-31 13F SAREPTA THERAPEUTICS COM 803607100 167,182 -21,393 -11.34 18,244 -40.10 0.0055
2019-04-23 2018-09-30 13F/A-2 SAREPTA THERAPEUTICS COM 803607100 188,575 -121,631 -39.21 30,457 -25.72 0.0076
2018-11-20 2018-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 188,575 0 30,457 0.0076
2018-11-14 2018-09-30 13F SAREPTA THERAPEUTICS COM 803607100 188,575 -121,631 30,457
2019-04-23 2018-06-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 310,206 -212,378 -40.64 41,002 5.90 0.0111
2018-08-14 2018-06-30 13F SAREPTA THERAPEUTICS COM 803607100 310,206 -212,378 41,002
2019-04-23 2018-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 522,584 -305,453 -36.89 38,719 -15.96 0.0107
2018-05-14 2018-03-31 13F SAREPTA THERAPEUTICS COM 803607100 522,584 -305,453 38,719
2019-04-23 2017-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 828,037 566,915 217.11 46,072 288.99 0.0126
2018-02-14 2017-12-31 13F SAREPTA THERAPEUTICS COM 803607100 828,037 566,915 46,072
2017-11-14 2017-09-30 13F SAREPTA THERAPEUTICS COM 803607100 261,122 82,938 46.55 11,844 97.17 0.0035
2017-08-11 2017-06-30 13F SAREPTA THERAPEUTICS COM 803607100 178,184 -11,926 -6.27 6,007 6.73 0.0018
2017-05-22 2017-03-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 190,110 -19,174 -9.16 5,628 -1.97 0.0017
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS COM 803607100 190,110 5,628
2017-02-22 2016-12-31 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 209,284 -274,263 -56.72 5,741 -80.67 0.0019
2017-02-13 2016-12-31 13F SAREPTA THERAPEUTICS COM 803607100 209,284 5,741
2016-11-10 2016-09-30 13F SAREPTA THERAPEUTICS COM 803607100 483,547 -484,180 -50.03 29,695 60.90 0.0101
2016-08-12 2016-06-30 13F SAREPTA THERAPEUTICS COM 803607100 967,727 522,049 117.14 18,455 112.18 0.0067
2016-05-12 2016-03-31 13F SAREPTA THERAPEUTICS COM 803607100 445,678 311,893 233.13 8,698 68.50 0.0033
2016-02-09 2015-12-31 13F SAREPTA THERAPEUTICS COM 803607100 133,785 24,477 22.39 5,162 47.07 0.0019
2016-02-08 2015-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 109,308 -11,753 -9.71 3,510 -4.72 0.0013
2015-11-09 2015-09-30 13F SAREPTA THERAPEUTICS COM 803607100 109,308 3,510
2015-08-12 2015-06-30 13F SAREPTA THERAPEUTICS COM 803607100 121,061 48,123 65.98 3,684 280.19 0.0013
2015-05-14 2015-03-31 13F SAREPTA THERAPEUTICS COM 803607100 72,938 1,102 1.53 969 -6.83 0.0004
2015-02-13 2014-12-31 13F SAREPTA THERAPEUTICS COM 803607100 71,836 -29,493 -29.11 1,040 -51.36 0.0004
2014-12-16 2014-09-30 13F/A-1 SAREPTA THERAPEUTICS COM 803607100 101,329 14,483 16.68 2,138 2.44 0.0008
2014-11-14 2014-09-30 13F SAREPTA THERAPEUTICS COM 803607100 101,329 2,138
2014-05-13 2014-03-31 13F SAREPTA THERAPEUTICS COM 803607100 86,846 29,782 52.19 2,087 79.45 0.0009
2014-02-13 2013-12-31 13F SAREPTA THERAPEUTICS COM 803607100 57,064 -282,756 -83.21 1,163 -92.75 0.0005
2013-11-13 2013-09-30 13F SAREPTA THERAPUTICS COM 803607100 339,820 266,087 360.88 16,050 472.40 0.0076
2013-08-08 2013-06-30 13F SAREPTA THERAPUTICS COM 803607100 73,733 73,733 2,804 0.0014
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.